Page last updated: 2024-09-05

pneumadin and Atrophy

pneumadin has been researched along with Atrophy in 2 studies

*Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Konwerska, A; Kosowicz, J; Malendowicz, LK; Miśkowiak, B; Nussdorfer, GG; Ziółkowska, A1
Andreis, PG; Malendowicz, LK; Markowska, A; Miskowiak, B; Nussdorfer, GG1

Other Studies

2 other study(ies) available for pneumadin and Atrophy

ArticleYear
Pneumadin in the ventral prostate and seminal vesicles of estradiol-treated rats: RIA and immunocytochemical studies.
    Folia histochemica et cytobiologica, 2003, Volume: 41, Issue:4

    Topics: Animals; Atrophy; Down-Regulation; Drug Administration Schedule; Epithelial Cells; Estradiol; Immunohistochemistry; Male; Oligopeptides; Prostate; Radioimmunoassay; Rats; Rats, Wistar; Reproduction; Seminal Vesicles

2003
Effects of pneumadin (PNM) on the adrenal glands. 6. Further studies on the inhibitory effect of PNM on dexamethasone-induced atrophy of the rat adrenal cortex.
    Histology and histopathology, 1997, Volume: 12, Issue:3

    Topics: Adrenal Cortex; Aldosterone; Animals; Atrophy; Cell Size; Corticosterone; Dexamethasone; Dose-Response Relationship, Drug; Female; Oligopeptides; Organ Size; Rats; Rats, Wistar; Time Factors

1997